Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Ixekizumab effectively treats generalized pustular psoriasis.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Turmeric may have benefits for skin health, but more research is needed to confirm its effectiveness.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The British Association of Dermatologists celebrated 100 years by looking back at important research, including work on hair loss, skin condition impact, psoriasis treatment, and skin cancer rates.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

Stress can worsen skin conditions by affecting hormone levels and immune response.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

Vitamins A, B3, C, D, and E can improve skin health and immunity.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.